<br>        Inclusion Criteria:<br><br>          -  Daily intake of low-dose Aspirin (ASA) - The subject must fulfill at least one of the<br>             following (a-e):<br><br>          -  Aged =65 years.<br><br>          -  Aged =18 years and with a documented history of uncomplicated peptic ulcer(s).<br><br>          -  Aged =60 years and naïve to low-dose ASA (ie, treatment started within 1 month prior<br>             to randomization).<br><br>          -  Aged =60 years and with stable coronary artery disease.<br><br>          -  Aged =60 years and with complaints of upper gastrointestinal (GI) symptoms that, as<br>             judged by the investigator, requires an Esophagogastroduodenoscopy (EGD) and with the<br>             finding of =5 gastric and/or duodenal erosions at the baseline endoscopy.<br><br>        Exclusion Criteria:<br><br>          -  Peptic ulcer(s) at baseline esophagogastroduodenoscopy (EGD).<br><br>          -  Reflux esophagitis Los Angeles (LA) classification grade C or D at baseline<br><br>          -  History of peptic ulcer complications such as clinically significant bleeding and/or<br>             perforation.<br>      ;<br>        Inclusion Criteria:<br><br>          -  Daily intake of low-dose Aspirin (ASA) - The subject must fulfill at least one of the<br>             following (a-e):<br><br>          -  Aged =65 years.<br><br>          -  Aged =18 years and with a documented history of uncomplicated peptic ulcer(s).<br><br>          -  Aged =60 years and naïve to low-dose ASA (ie, treatment started within 1 month prior<br>             to randomization).<br><br>          -  Aged =60 years and with stable coronary artery disease.<br><br>          -  Aged =60 years and with complaints of upper gastrointestinal (GI) symptoms that, as<br>             judged by the investigator, requires an Esophagogastroduodenoscopy (EGD) and with the<br>             finding of =5 gastric and/or duodenal erosions at the baseline endoscopy.<br><br>        Exclusion Criteria:<br><br>          -  Peptic ulcer(s) at baseline esophagogastroduodenoscopy (EGD).<br><br>          -  Reflux esophagitis Los Angeles (LA) classification grade C or D at baseline<br><br>          -  History of peptic ulcer complications such as clinically significant bleeding and/or<br>             perforation.<br>      ;<br>        Inclusion Criteria:<br><br>          -  Daily intake of low-dose Aspirin (ASA) - The subject must fulfill at least one of the<br>             following (a-e):<br><br>          -  Aged =65 years.<br><br>          -  Aged =18 years and with a documented history of uncomplicated peptic ulcer(s).<br><br>          -  Aged =60 years and naïve to low-dose ASA (ie, treatment started within 1 month prior<br>             to randomization).<br><br>          -  Aged =60 years and with stable coronary artery disease.<br><br>          -  Aged =60 years and with complaints of upper gastrointestinal (GI) symptoms that, as<br>             judged by the investigator, requires an Esophagogastroduodenoscopy (EGD) and with the<br>             finding of =5 gastric and/or duodenal erosions at the baseline endoscopy.<br><br>        Exclusion Criteria:<br><br>          -  Peptic ulcer(s) at baseline esophagogastroduodenoscopy (EGD).<br><br>          -  Reflux esophagitis Los Angeles (LA) classification grade C or D at baseline<br><br>          -  History of peptic ulcer complications such as clinically significant bleeding and/or<br>             perforation.<br>      ;<br>        Inclusion Criteria:<br><br>          -  Daily intake of low-dose Aspirin (ASA) - The subject must fulfill at least one of the<br>             following (a-e):<br><br>          -  Aged =65 years.<br><br>          -  Aged =18 years and with a documented history of uncomplicated peptic ulcer(s).<br><br>          -  Aged =60 years and naïve to low-dose ASA (ie, treatment started within 1 month prior<br>             to randomization).<br><br>          -  Aged =60 years and with stable coronary artery disease.<br><br>          -  Aged =60 years and with complaints of upper gastrointestinal (GI) symptoms that, as<br>             judged by the investigator, requires an Esophagogastroduodenoscopy (EGD) and with the<br>             finding of =5 gastric and/or duodenal erosions at the baseline endoscopy.<br><br>        Exclusion Criteria:<br><br>          -  Peptic ulcer(s) at baseline esophagogastroduodenoscopy (EGD).<br><br>          -  Reflux esophagitis Los Angeles (LA) classification grade C or D at baseline<br><br>          -  History of peptic ulcer complications such as clinically significant bleeding and/or<br>             perforation.<br>